BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17498766)

  • 1. Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene.
    Sugiyama M; Tanaka Y; Kurbanov F; Nakayama N; Mochida S; Mizokami M
    Virology; 2007 Sep; 365(2):285-91. PubMed ID: 17498766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characteristics and functional analysis of full-length hepatitis B virus quasispecies from a patient with chronic hepatitis B virus infection.
    Cui XJ; Cho YK; Song HJ; Choi EK; Kim HU; Song BC
    Virus Res; 2010 Jun; 150(1-2):43-8. PubMed ID: 20184927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of HBV genomes from patients with fulminant hepatitis.
    Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
    Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital.
    Laoi BN; Crowley B
    J Med Virol; 2008 Sep; 80(9):1554-64. PubMed ID: 18649329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implications of clustering changes in a small region of the HBV core region.
    Hur GM; Lee YI; Suh DJ; Lee JH; Lee YI
    J Med Virol; 1996 Jan; 48(1):38-46. PubMed ID: 8825708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of natural occurrence of two closely linked HBV precore predominant mutations.
    Yuan TT; Faruqi A; Shih JW; Shih C
    Virology; 1995 Aug; 211(1):144-56. PubMed ID: 7645207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?
    Cheng Y; Seet BL; Ong CS; Wasser S; Tan TM; Peter FJ; Lim SG
    Antiviral Res; 2006 Mar; 69(3):142-51. PubMed ID: 16406140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
    Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis.
    Veazjalali M; Norder H; Magnius L; Jazayeri SM; Alavian SM; Mokhtari-Azad T
    J Viral Hepat; 2009 Apr; 16(4):259-64. PubMed ID: 19222745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of hepatitis B virus in Iran.
    Mohebbi SR; Amini-Bavil-Olyaee S; Zali N; Noorinayer B; Derakhshan F; Chiani M; Rostami Nejad M; Antikchi MH; Sabahi F; Zali MR
    Clin Microbiol Infect; 2008 Sep; 14(9):858-66. PubMed ID: 18844687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.
    Fujiwara K; Tanaka Y; Paulon E; Orito E; Sugiyama M; Ito K; Ueda R; Mizokami M; Naoumov NV
    J Virol; 2005 Nov; 79(22):14404-10. PubMed ID: 16254374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
    Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
    J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-replication analyses of naturally occurring defective hepatitis B virus variants with wild-type.
    Märschenz S; Brinckmann A; Nürnberg P; Krüger DH; Günther S; Meisel H
    Virology; 2008 Mar; 372(2):247-59. PubMed ID: 18061229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of precore/core and partial pol genes in an unprecedented outbreak of fulminant hepatitis B in India.
    Khare S; Negi SS; Singh S; Singhal M; Kumar S; Prakash C; Venugopal R; Rawat DS; Chauhan LS; Rai A
    Epidemiol Infect; 2012 Oct; 140(10):1823-9. PubMed ID: 22417682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hepatitis B virus quasispecies distribution in a Korean chronic patient based on the full genome sequences.
    Kim H; Jee YM; Song BC; Hyun JW; Mun HS; Kim HJ; Oh EJ; Yoon JH; Kim YJ; Lee HS; Hwang ES; Cha CY; Kook YH; Kim BJ
    J Med Virol; 2007 Mar; 79(3):212-9. PubMed ID: 17245716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type B fulminant hepatitis is closely associated with a highly mutated hepatitis B virus strain.
    Kanada A; Takehara T; Ohkawa K; Tatsumi T; Sakamori R; Yamaguchi S; Uemura A; Kohga K; Sasakawa A; Hikita H; Hijioka T; Katayama K; Deguchi M; Kagita M; Kanto T; Hiramatsu N; Hayashi N
    Intervirology; 2007; 50(6):394-401. PubMed ID: 17975320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the relevance of the mutations of the precore and basic core promoter in HBV genome with the DNA amount of HBV viremia].
    Kaijima H; Yukimasa N; Sugano E; Yasuhara T; Fukuchi K; Gomi K
    Rinsho Byori; 2009 Apr; 57(4):332-7. PubMed ID: 19489434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.